• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Brovana (arformoterol) Inhalation Solution

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

 

February 2014

Summary View

6 ADVERSE REACTIONS

6.2 Clinical Trials Experience
  • Clinical Trial data added…Adults with COPD in Long-Term (52-week) Safety Trial

 

February 2011

Summary View

 

MEDICATION GUIDE

  • ... information about the risk of serious asthma outcomes (asthma related death, intubations, and hospitalization) ...